Gilead's Kite And Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination Of Yescarta And Mavrilimumab In Relapsed Or Refractory Large B-Cell Lymphoma
Benzinga Newsdesk